Pages that link to "Q28240354"
Jump to navigation
Jump to search
The following pages link to Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws (Q28240354):
Displaying 50 items.
- Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ) (Q24186105) (← links)
- Bisphosphonate therapy for osteogenesis imperfecta (Q24194821) (← links)
- Bisphosphonates and other bone agents for breast cancer (Q24203656) (← links)
- Interventions for treating osteonecrosis of the jaw bones associated with bisphosphonates (Q24236073) (← links)
- Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women (Q24242258) (← links)
- Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women (Q24242674) (← links)
- Bisphosphonates for breast cancer (Q24246519) (← links)
- Giant osteoclast formation and long-term oral bisphosphonate therapy (Q24626459) (← links)
- Bisphosphonates: mechanism of action and role in clinical practice (Q24644708) (← links)
- MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis (Q26752588) (← links)
- National consensus in China on diagnosis and treatment of patients with advanced breast cancer (Q26775621) (← links)
- Bisphosphonate Related Osteonecrosis of the Jaw: An Update (Q26801664) (← links)
- Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients (Q26824762) (← links)
- Osteochemonecrosis: an overview (Q26827072) (← links)
- A review of denosumab for the treatment of osteoporosis (Q27005894) (← links)
- Skeletal complications of bisphosphonate use: what the radiologist should know (Q27010157) (← links)
- Dental complications and management of patients on bisphosphonate therapy: A review article (Q27022492) (← links)
- American Society of Biomechanics Journal of Biomechanics Award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures (Q27027254) (← links)
- Hovenia dulcis Thunb extract and its ingredient methyl vanillate activate Wnt/β-catenin pathway and increase bone mass in growing or ovariectomized mice (Q28538976) (← links)
- "Phossy Jaw" and "Bis-phossy Jaw" of the 19th and the 21st Centuries: The Diuturnity of John Walker and the Friction Match (Q28601698) (← links)
- (Q29039477) (redirect page) (← links)
- Cathepsin K inhibitors for osteoporosis and potential off-target effects (Q29042565) (← links)
- Cancer treatment-related bone disease (Q30438185) (← links)
- Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men. (Q30443800) (← links)
- Cancer-associated bone disease (Q30444698) (← links)
- Molecular mechanisms and treatment of bone metastasis (Q30445717) (← links)
- Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice (Q30492459) (← links)
- Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates-Preliminary data: Medical ozone gas insufflation in treating ONJ lesions (Q31048683) (← links)
- Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology (Q31146923) (← links)
- Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia (Q33282322) (← links)
- Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study (Q33297907) (← links)
- Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle (Q33344882) (← links)
- Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study (Q33370496) (← links)
- Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids. (Q33387310) (← links)
- Tolerability of intravenous pamidronate for the treatment of osteoporosis and other metabolic osteopathies: A retrospective analysis (Q33414289) (← links)
- Osteonecrosis of the jaws caused by bisphosphonates: evaluation of a new therapeutic approach using the Er:YAG laser (Q33416973) (← links)
- Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates (Q33553916) (← links)
- Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw. (Q33555823) (← links)
- Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report (Q33594764) (← links)
- Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects (Q33594793) (← links)
- Estrogen regulation of apoptosis in osteoblasts (Q33675169) (← links)
- Influence of bisphosphonates on alveolar bone density: a histomorphometric analysis (Q33705366) (← links)
- The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK (Q33706654) (← links)
- Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis (Q33773125) (← links)
- Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer (Q33789201) (← links)
- A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis (Q33810748) (← links)
- Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer (Q33813626) (← links)
- Implant failure associated with oral bisphosphonate-related osteonecrosis of the jaw. (Q33861392) (← links)
- Osteonecrosis of the jaw in a patient on Denosumab (Q33891868) (← links)
- Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report (Q33898150) (← links)